chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Admit date: 2/12/2021 Discharge date and time: 2/14/21 Admission Diagnosis: DOE (dyspnea on exertion)  Hospital Problems:  Active Problems: Pulmonary fibrosis (HCC) (8/24/2015) POA: Yes Elevated troponin (11/22/2020): Yes Cardiac pacemaker in situ (11/23/2020): Yes PAF (paroxysmal atrial fibrillation) (HCC) (11/23/2020) POA: Yes Recurrent major depressive disorder (HCC) (11/23/2020) POA: Yes DOE (dyspnea on exertion) (2/12/2021) POA: Yes Acute on chronic systolic (congestive) heart failure (HCC) (2/13/2021) POA: Yes
About five days after the first shot, I developed a skin rash on my left abdomen.   It was very itchy.  After the second Pfizer vaccine, it spread all over my body.  I still have it despite a course of topical and ingested steroids and an antibiotic.
In mid October 2021, I had cold symptoms. I had headache, runny nose, fever, congestion, fatigue and a slight cough. I did a virtual visit with my doctor. I did over the counter cold medicine and it lasted about 2 weeks. I did a COVID test that was negative.
Patients daughter called 1/21/22 to follow up on the Prevnar vaccine her mother received (recommended by provider) on 1/11/22. She said the day after receiving vaccine her mother felt some chest tightness and shortness of breath. She went to the doctor and it was discovered her O2 levels were low and she was not feeling well. Since then her condition worsened and she was admitted to hospital with double pneumonia and covid.
right ear irritation moving to ear pressure to ear pain behind ear lobe; right ear irritation moving to ear pressure to ear pain behind ear lobe; headache; right side of mouth canker sore; right side of head jaw pain; This is a spontaneous report from a contactable consumer (patient). This 55-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EL9269) via an unspecified route on 11Feb2021 at 12:00 (at the age of 55-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included erratic blood pressure and Von Willebrand Syndrome. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included levothyroxine and hydrochlorothiazide from unspecified dates for unspecified indications. The patient received dose 1 of BNT162B2 (lot number EL9261) on 20Jan2021 at 11:30 as a single dose in the left arm for COVID-10 immunization. The patient did not have any allergies to medications, food, or other products. On 19Feb2021 at 07:00 the patient experienced right ear irritation moving to ear pressure to ear pain behind ear lobe, right side of mouth canker sore, right side of head jaw pain, and headache. The patient visited a doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The outcomes of right ear irritation moving to ear pressure to ear pain behind ear lobe, right side of mouth canker sore, right side of head jaw pain, and headache were not recovered. It was also reported that since the vaccine the patient had not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
I have been in and out of hospital because of being dehydrated after vaccine.; Diarrhea; I had watery diarrhea and couldn't eat anything because this continued happened; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and DEHYDRATION (I have been in and out of hospital because of being dehydrated after vaccine.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Irritable bowel syndrome. Concurrent medical conditions included Sleep disorder.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced DECREASED APPETITE (I had watery diarrhea and couldn't eat anything because this continued happened). On 21-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) (seriousness criterion medically significant). On an unknown date, the patient experienced DEHYDRATION (I have been in and out of hospital because of being dehydrated after vaccine.) (seriousness criterion medically significant). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) for Diarrhea, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), DEHYDRATION (I have been in and out of hospital because of being dehydrated after vaccine.) and DECREASED APPETITE (I had watery diarrhea and couldn't eat anything because this continued happened) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication also included unspecified IV fluids and fodmap diet. Concomitant medication included unspecified medicine to sleep at night  Company Comment:  Very limited information regarding this event/s has been provided at this time.  Further information has been requested.   This case was linked to MOD-2021-225401 (Patient Link).; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 28-OCT-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB (exposed to the following temperatures and cumulative time frames colder than 36F: In September of 2015, the coldest temperature was 34F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34F for 192 hours, for a total of 1,031.3 hours (43 days)) with lot number: L010595, expiry date: 12-NOV-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
First Dose 2/26/2021: 1. sore arm where shot was administered for about 5 days. 2. Two weeks after vaccination I came down with flu like symptoms including: muscle aches, fever, chills, severe headache, and extremely tired which last for five days. 3. No medication would relieve the symptoms including the headache. 4. Had to stay in bed or on couch entire weekend. Second Dose 3/19/2021: 1. Five hours after vaccination, I cam down with the same flu like systems including: muscle aches, fever, chills and severe headache, which lasted for another five days.  This time it also kicked off my Graves eye disease. 2. Shot made the arm feel very heavy and hard to use. 3. No medication would relieve the symptoms.
Consumer received 1st dose on 30Jan2021 and wants second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Consumer received 1st dose on 30Jan2021 and wants second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Consumer received 1st dose on 30Jan2021 and wants second dose). On 30-Jan-2021, PRODUCT DOSE OMISSION ISSUE (Consumer received 1st dose on 30Jan2021 and wants second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter.   Treatment information was not provided.
Significant rash to trunk and extremities. Maculopapular type consistent w/drug Rx.
Swollen left thumb, left index finger swollen, both being numb.  Pain in upper arm.
The following day, he started developing low grade fevers, and was not feeling too well. One day prior to admission, he started developing some difficulty breathing, with sore throat as well. Around 3:30AM on morning of admission, he felt some chest tightness (described as pressure like, with a tingling sensation) without any worsening difficulty breathing.
Patient presented to vaccine clinic on 9/8/21 for second dose of Moderna COVID19 vaccine.  Second dose was administered.  After dose given, vaccine staff realized when entering into state immunization registry that the first dose of Moderna was given on 8/18/21,and that is second dose should have been given on 9/15.  This meant patient received second dose on day 22 instead of day 28, and was recognized to be a dosing interval error.  Patient was contacted and notified of error.  Reported subjective fever and myalgia for one day after vaccination, but all vaccine side effects resolved within 36 hours.  Patient instructed that a repeat second dose is not needed.
Patient developed Guillain Barre Syndrome 7 weeks following influenza vaccine, 3.5 weeks following DTP vaccine.
The case was received on 21 March 2014 at GPV. Initial misuse report received from a Consumer on 18 September 2013. A male patient had received 0.5 ml dose of FLUZONE HD instead of FLUZONE on an unspecified date. The patient has a history of seasonal allergies, food allergies, nuts and peanuts. No adverse event was reported. List of documents held by sender: none
Around 4 am. Fever of 100.2 and chills that lasted about 12 hours. Headache that was unrelieved by medication that lasted 24 hours. Fatigue that lasted 24 hours. Severe injection site pain that lasted 12 hours. Nausea that lasted about 12 hours.
PROQUAD underwent a temperature excursion and was administered; This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On 18-JUN-2021, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # T036562 exp date 26-APR-2022) rHA (dose and route not reported) that underwent a temperature excursion. Previous temperature of excursion was 6°F to 14°F (14F) for 2 hours, 14°F to 46°F (45.5F) 1 hour and 30 minutes and 6°F t o14°F (14.4F) for 2 hours.  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-2106USA006064: US-009507513-2106USA006458: US-009507513-2106USA006459: US-009507513-2106USA006460: US-009507513-2106USA006461: US-009507513-2106USA006462: US-009507513-2106USA006463: US-009507513-2106USA006464: US-009507513-2106USA006465: US-009507513-2106USA006466: US-009507513-2106USA006467: US-009507513-2106USA006468: US-009507513-2106USA006469: US-009507513-2106USA006470: US-009507513-2106USA006471: US-009507513-2106USA006472: US-009507513-2106USA006473: US-009507513-2106USA006474: US-009507513-2106USA006475: US-009507513-2106USA006477: US-009507513-2106USA006478: US-009507513-2106USA006479: US-009507513-2106USA006480: US-009507513-2106USA006481: US-009507513-2106USA006482: US-009507513-2106USA006483: US-009507513-2106USA006484: US-009507513-2106USA006485: US-009507513-2106USA006486: US-009507513-2106USA006487: US-009507513-2106USA006488: US-009507513-2106USA006489: US-009507513-2106USA006490: US-009507513-2106USA006491: US-009507513-2106USA006492: US-009507513-2106USA006493: US-009507513-2106USA006494: US-009507513-2106USA006495: US-009507513-2106USA006496: US-009507513-2106USA006497: US-009507513-2106USA006498:
I had very slight itching and soreness at the injection site after the shot.  However, one week after the shot on January 23 I developed pronounced itching, a significant rash, and a significant bum/swelling at the injection site.  The rash became bigger and continues through today, January 25.
Pt developed rapid heartbeat and high blood pressure the day following the injection. These were not getting better, so after several hours pt had to go to Urgent Care to be evaluated further. It was advised pt go to ER for f/u.
She has shrunk; weighs less. Maybe 154 pounds. She was 170; she got first dose of Pfizer COVID vaccine on Monday 04Jan2021/She will get the second dose on 01Feb2021; she got first dose of Pfizer COVID vaccine on Monday 04Jan2021/She will get the second dose on 01Feb2021; had congestion; Coughing; choking; body was more than hot it was burning/body turned very hot; could not sleep/two sleepless nights; This is a spontaneous report from a contactable consumer. A 78-year-old female patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 04Jan2021 at a single dose for COVID-19 immunization, ciprofloxacin (CIPRO), via an unspecified route of administration from an unspecified date at an unknown dose and frequency for an unspecified indication and pirfenidone (ESBRIET), via an unspecified route of administration from an unspecified date at an unknown dose and frequency for an unspecified indication. Medical history included pulmonary fibrosis (diagnosed between 2007-2010), Lymphoma type B, blood pressure (abnormal), cholesterol (abnormal), vertigo, biopsy, tightening of legs and feet, drip (nasal) and pain. Concomitant medication included gabapentin for tightening of her legs and feet, diphenhydramine hydrochloride (BENADRYL) for drip (nasal) and meloxicam for pain. It was reported that the patient took the vaccine and had two sleepless nights on 05Jan2021, her body turned very hot but she have some conditions. Sleepless nights: they have been really rough nights. Scary. Coughing and choking. She thinks the vaccine kicked in and started beating the hell out of it. The patient clarified that she is having sleepless nights because of the coughing, choking, and burning and she feels that it is related to the vaccine kicking in. She slept last night, 14Jan2021. The cough is starting again today (as reported). She hopes it calms down. When she said her body was hot, like burning she was describing her sleepless nights. She is afraid. She is keeping in contact with her doctor. She figured she better call because more people are on this medication. The patient also experienced congestion on 06Jan2021. It was reported that the patient has shrunk and weighed less. Maybe 154 pounds. She was 170. The action taken for ciprofloxacin and pirfenidone was unknown. The outcome of the event congestion was not recovered, while unknown for the rest of the events.
Pt started vomiting with BP 65/41, flushing arms and looking pale. C/o blurry vision.  Airway intact, no throat clearing. Pulse ox over 95%.  Immediately transported to ER and safely discharged same day.
(R) arm swelling, redness, itchiness - cellulitis at injection and down arm. Treated with Keflex 500 mg BID x 7 days and Benadryl PRN.
Numbness, weakness, difficulty walking, aprox 5 days after flu shot. Plasmapheresis IVIG (several treatments of both) diagnosed w/GBS followed by CIDP.
This spontaneous report as received from a medical assistant refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On an unspecified date in 2016 (reported as "on or after 03-MAR-2016"), the patient was vaccinated with an improperly stored dose of ROTATEQ injection (lot # M002252 with expiry date: 28-FEB-2017, orally; strength, dose and site of administration were unspecified). The administered vaccine underwent the temperature excursion at 8.3 degrees Celsius for 19 minutes. There was no previous temperature excursion. It was a case of a "data logger". No concomitant medications were reported. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
On 4/5/21, two days after my second injection, I was sitting at my desk working (at home) when I noticed my vision wasn't clear even with my glasses on. I had been feeling nauseous for a few hours and then my eyes started bouncing back and forth uncontrollably. I was unable to see correctly or move from my chair. Once my eyes stopped moving my vision became tunnel vision and everything around it became foggy. I felt weak and dizzy. I started getting a headache. I didn't think I could even call out for help as I was unsure my voice would work. Once it all calmed down I figured it must be part of a migraine, even though nothing this extreme had ever happened before. I moved to my bed as I was suddenly completely exhausted, and immediately fell asleep for almost 3 hours. Once I got up I was still very groggy and had to force myself my. I stayed up for about 3 hours and went back to bed for the night. The next morning I woke and was feeling better so I figured it must have been a migraine. However a few hours later the same problems started back up again. I was having a hard time seeing my computer screen, I had a foggy head and was finding it hard to concentrate and do work. My headache started again and my vision started as foggy and became tunnel vision again. This time my eyes did not bounce, but my lips started tingling. This lasted for about 1 minute. This time with everything I was making sure to take a mental note of everything going on because I was scared I was going to have to call 911. Because I was home alone I opened my phone to dial if it got any worse. The event backed off enough that I took myself to the ER. By the time I was in the waiting room my head felt like a balloon and my whole body just felt "off." I can't explain how it felt, it just didn't feel normal. My headache never got overly severe like it does with a migraine, but I was worried about a stroke. The ER did a CT scan and did rule out a stroke, but was unsure of what it exactly what it was, but guessed it was an abnormal migraine attack and told me to follow up with my PCM in a couple of days and to keep my appointment with my neurologist on April 15th. The symptoms lasted a full week off and on every day, with a tampering down of severity of symptoms.
My left arm, shoulder, under arm, armpit, and breast had a noticeable amount of edema that has not resolved. Also by the end of week one my left knee was also swelling. Pain in arm is constant.
Sjogrens Syndrome symptoms were triggered, although never experienced before.  The outcome was a diagnosis of Sjogrens Syndrome.   Oral lichen planus existed, but was exacerbated after the vaccine.
Patient was admitted to Hospital on 11/27/2021 for COVID related symptoms. This is considered a breakthrough case.
Coughing after movement. Weezing, trouble breathing, Lethargy, high heart rate.  11/12/09:  Labs and Diagnostics received for dates of service 11/11/09 to 11/12/09.  Dx:  Pneumonia.
Patient feeling dizzy. Vital signs obtained, offered a drink and snack. Patient declined. Monitored longer and dizziness resolved. Wife drove patient home.
This case was reported by a nurse via call center representative and described the occurrence of urticaria in a adult female patient who received FLULAVAL QUADRIVALENT (batch number 7KK33, expiry date 30th April 2017). This case was associated with a product complaint. On 29th September 2016, the patient received FLULAVAL QUADRIVALENT (intramuscular). On 29th September 2016, 20 min after receiving FLULAVAL QUADRIVALENT, the patient experienced urticaria, formication and dry mouth. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the urticaria, formication, dry mouth and pharmaceutical product complaint were unknown. The reporter considered the urticaria to be almost certainly related to FLULAVAL QUADRIVALENT. It was unknown if the reporter considered the formication and dry mouth to be related to FLULAVAL QUADRIVALENT. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that that a female patient experienced urticaria, dry mouth and hives. She also reported formication. The reporter stated that a multi dose vial of FLULAVAL might be suspect. It had caused various adverse events in several patients with a similar adverse event pattern. The suspect vial was available for return. Replacement or credit was not requested by reporter. This case is 1 of the 3 cases reported by the same reporter.
12 hours after vaccine couldnt walk, extreme headache, never felt so bad in my whole life.  Slept for 2 days.  Continue to feel ill to this day.  Current symptoms include extreme fatigue, tremors, brain fog, pin stick feeling on arms and chest, difficulty concentrating and at time speaking
IM in left arm. Pt began having hives on right arm and chest per RN. Pt given benadryl 25 mg PO and Norco 5/325 PO.
No problem with vaccine.  I developed Covid 19, on May 25th, 2021.  Tested positive on May 26th, 2021.  virus was sequenced at the health lab, was the Alpha variant
VAERS note on patient who experienced a vasovagal episode following receiving Monkeypox vaccine today 09/15/2022 at approximately 2:10 PM.   Within approximately 1 minute of the administration of 0.1 ml intradermal Jynneos/BN vaccine in left forearm the client became pale and stated he was hot. He stated that he felt lightheaded. He appeared to be diaphoretic. No airway compromise was noted.  No difficulty breathing noted.  Client's legs were elevated onto an adjacent chair, and legs were visibly shaking when elevated to the chair. There was no loss of consciousness and no head trauma at any time.  No impact injury of any kind.  Client was conscious and verbalizing and answering questions appropriately through the entire experience.  Client was given alcohol swab to breathe through nose while vital signs were taken on right upper arm with NIBP device at close intervals.  SaO2 was measured on left index finger.  Vitals were also repeated on the right arm to compare values. All VS remained within normal limits.  Client stated he has never had an adverse reaction to any vaccine administration.  When client stated he was feeling improved and diaphoresis had abated, client was transitioned from sitting to standing so that vital signs could be measured at each position change.  The Client remained sitting for an additional 15 minutes in the vaccination room.    Assessment:  vasovagal response secondary to anxiety occasioned by receiving an injection.     Initial right arm vital signs noted below:   2:20 PM  - 89/68 sitting HR 61  SaO2 98%      Serial Left arm vital signs noted below:   2:29 PM  - 99/73 sitting HR 67 SaO2 100%    2:34 PM  - 95/65 standing SaO2 98%   2:47PM  - 100/70 standing HR 81 SaO2 99%     When client felt improved and returned to prevaccination state he was transferred to postvaccination waiting area and instructed to remain for an additional 15 minutes before leaving and to communicate with postvaccination area nurses if he felt lightheaded again.
on 3/18/21 she began having malaise, chills, body aches but no fever. On 2/20 she started having stabbing back pain and sternal pain. On 2/21 her daughter noted a red rash on her back. At office visit today, 2/24/21 she had a significant case of Shingles with confluent red, vesicular rash at about T5-6 level from mid back to under her right breast. She was started on Valtrex and gabapentin
Horrible muscle and nerve pain in lower extremities.  Burning sensation  with shooting pain, numbness, and tingling in lower extremities. Feet contract and I am unable to walk on them if I do not keep them flat.
Painful red rash and swelling of upper arm x 5 days. Treated with cephalexin TID x 7 days